Determination of skeletal tumor extent: is an isotropic T1-weighted 3D sequence adequate?

Author(s):  
Rodrigo Luna ◽  
Jan Fritz ◽  
Filippo del Grande ◽  
Shivani Ahlawat ◽  
Laura M. Fayad
Keyword(s):  
2013 ◽  
Vol 43 (8) ◽  
pp. 1017-1023 ◽  
Author(s):  
Ney Tatizawa Shiga ◽  
Filippo Del Grande ◽  
Olivia Lardo ◽  
Laura M. Fayad

2015 ◽  
Vol 48 (3) ◽  
pp. 175-180 ◽  
Author(s):  
Júlio Brandão Guimarães ◽  
Letícia Rigo ◽  
Fabio Lewin ◽  
André Emerick

Abstract The effective evaluation for the treatment of patients with Ewing tumors depends on the accuracy in the determination of the primary tumor extent and the presence of metastatic disease. Currently, no universally accepted staging system is available to assess Ewing tumors. The present study aimed at discussing the use of PET/CT as a tool for staging, restaging and assessment of therapeutic response in patients with Ewing tumors. In spite of some limitations of PET/CT as compared with anatomical imaging methods, its relevance in the assessment of these patients is related to the capacity of the method to provide further physiological information, which often generates important clinical implications. Currently, the assessment of patients with Ewing tumor should comprise a study with PET/CT combined with other anatomical imaging modalities, such as radiography, computed tomography and magnetic resonance imaging.


1997 ◽  
Vol 15 (6) ◽  
pp. 2420-2431 ◽  
Author(s):  
V E Sutliff ◽  
J L Doppman ◽  
F Gibril ◽  
D J Venzon ◽  
F Yu ◽  
...  

PURPOSE The growth pattern of untreated metastatic neuroendocrine tumors is unknown. This uncertainty contributes to the disagreement regarding timing and could effect evaluation of the efficacy of antitumor treatment. The purpose of this study was to determine the growth rate of untreated hepatic metastatic gastrinoma and to identify its predictors. PATIENTS AND METHODS Nineteen patients with histologically proven metastatic gastrinoma in the liver with Zollinger-Ellison syndrome were studied. Conventional imaging studies were performed initially and at 4- to 6-month intervals before any treatment. Metastases growth rates were calculated and correlated with laboratory and clinical parameters, as well as tumor extent on initial tumor assessment. RESULTS Twenty-six percent of patients (five of 19) demonstrated no growth over a mean follow-up time of 29 months, 32% (six of 19) had slow growth (1% to 50% increase in volume per month) over a 19-month period, and 42% (eight of 19) had rapid growth (> 50% volume increase per month) over an 11-month period. In patients with rapid growth, 62% died; 0% of the no-growth or slow-growth group died. No clinical or laboratory parameter correlated with growth rate, except the rate increase in fasting serum gastrin and the presence of bilobar liver or bone metastases. The growth rate was highly predictive of death from tumor. CONCLUSION The growth rate of metastatic gastrinoma varies markedly in different patients and 26% demonstrate no growth. The growth rate needs to considered in the determination of when and in whom antitumor therapy is initiated, as well as in the assessment of response to tumoricidal therapies.


Radiology ◽  
1995 ◽  
Vol 194 (1) ◽  
pp. 135-139 ◽  
Author(s):  
T M Weber ◽  
H D Sostman ◽  
C E Spritzer ◽  
R L Ballard ◽  
G A Meyer ◽  
...  

2011 ◽  
Vol 34 (5) ◽  
pp. 265-275 ◽  
Author(s):  
Jason Hipp ◽  
Jerome Cheng ◽  
Stephanie Daignault ◽  
Jefferey Sica ◽  
Michael C. Dugan ◽  
...  

Recently, with the advent of the 7th edition of the AJCC Cancer Staging manual, at least one set of criteria (e.g. breast) were modified to now require the measurement of maximal depth of stromal invasion. With the current manual interpretive morphological approaches typically employed by surgical pathologists to assess tumor extent, the specialty now potentially has stumbled upon a crossroads of practice, where the diagnostic criteria have exceeded the capabilities of our commonly available tools. While whole slide imaging (WSI) technology holds the potential to offer many improvements in clinical workflow over conventional slide microscopy including unambiguous utility for facilitating quantitative diagnostic tasks with one important example being the determination of both linear dimension and surface area. However, the availability of histology data in digital form is of little utility if time-consuming and cumbersome manual workflow steps are necessarily imposed upon the pathologist in order to generate such measurements, especially as encountered with the complex and ill-defined shapes inherent to infiltrative tumors. In this communication, we demonstrate the utility of the recently described SIVQ algorithm to serve as the basis of a highly accurate, precise and semi-automated tool for direct surface area measurement of tumor infiltration from WSI data sets. By anticipating the current trend in cancer staging that emphasizes increasingly precise feature characterization, as witnessed by the recent publication of AJCC's 7th edition of the Cancer Staging Manual, this tool holds promise to will be of value to pathologists for clinical utility.


1981 ◽  
Vol 89 (6) ◽  
pp. 965-968 ◽  
Author(s):  
Linda J. Gardiner ◽  
Clarence T. Sasaki ◽  
Karen Hermansen ◽  
Jerome Sugar ◽  
Alexander S. Geha

A case of tracheal obstruction by invasive papillary thyroid carcinoma is described. In this paper we will show how selection and interpretation of diagnostic studies including computed tomographic scan allowed accurate determination of tumor extent and, therefore, an accurate selection of surgical procedures.


Sign in / Sign up

Export Citation Format

Share Document